There is no routine clinical test that tells you how much serotonin is active in your brain. The tests that do exist measure serotonin or its breakdown products in blood, urine, or spinal fluid, and each one captures a different slice of a complicated picture. Doctors order serotonin-related lab work for specific medical conditions, most commonly to investigate certain tumors, but the kind of test many people imagine when they wonder whether their serotonin is “low” does not exist in standard medicine. Understanding why requires knowing a bit about where serotonin lives in the body and what each available test actually measures.
Two Separate Serotonin Pools
The biggest reason serotonin testing is complicated is that your body maintains two largely independent serotonin systems. The serotonin in your brain is made by a small cluster of neurons in the brainstem and works as a neurotransmitter, influencing mood, sleep, and cognition. The serotonin in the rest of your body is produced mainly by specialized cells lining the gut and plays roles in digestion, blood clotting, and immune function. These two pools are separated by the blood-brain barrier, a tightly controlled boundary that serotonin cannot cross.1Europe PMC. Does Serotonin in the intestines make you happy? Once serotonin is released from gut cells, most of it gets swept up by platelets in the bloodstream, which store it and release it when needed.2PubMed. Role of platelet serotonin in innate immune cell recruitment
This separation means that a blood draw measuring your serotonin level is sampling the peripheral pool, which is overwhelmingly gut-derived and platelet-stored serotonin. It tells you nothing reliable about what is happening with serotonin signaling in your brain. When someone asks “how do I test my serotonin levels,” they usually want to know about the brain side of the equation, and that is precisely the side that a standard blood test cannot reach.
The Test Doctors Actually Order
The most common clinical reason to measure serotonin-related compounds is to investigate carcinoid tumors, a type of neuroendocrine tumor that can overproduce serotonin. The standard test for this is a 24-hour urine collection measuring 5-hydroxyindoleacetic acid, or 5-HIAA, which is the main breakdown product of serotonin. Elevated 5-HIAA in urine strongly suggests that the body is churning out excess serotonin, and the test is highly accurate for detecting carcinoid syndrome, with sensitivity reported at 100% and specificity around 85 to 90%.3PubMed Central. Urinary 5-Hydroxyindolacetic Acid Measurements in Patients with Neuroendocrine Tumor-Related Carcinoid Syndrome: State of the Art The test is especially useful for midgut carcinoid tumors, which tend to produce the highest amounts of serotonin.4AACE Clinical Case Reports. Falsely Elevated 24-Hour Urine 5-Hydroxyindoleacetic Acid Due to Dietary Intake: A Case Report and Review of the Literature
If your doctor orders a 5-HIAA urine test, it is almost certainly because they suspect a serotonin-producing tumor, not because they are checking your mood-related brain chemistry. The test is a workhorse in oncology and endocrinology, but it was never designed to evaluate depression, anxiety, or other psychiatric conditions.
Blood Serotonin Tests and Their Limits
Some labs can measure serotonin directly in blood serum using advanced techniques such as high-performance liquid chromatography with mass spectrometry, which can detect serotonin across a wide range of concentrations.5PubMed. Analysis of Serum Serotonin by High-Performance Liquid Chromatography-Tandem Mass Spectrometry Using Online Solid-Phase Extraction These tests are technically precise but practically tricky, because the way a blood sample is collected, handled, and processed has a huge effect on the result. Platelets are fragile, and the mechanical stress of drawing blood, the type of anticoagulant used, the temperature during centrifugation, and even the diameter of the needle can cause platelets to release their stored serotonin into the surrounding plasma. Different handling procedures lead to widely varying serotonin readings from the same patient.6Practical Laboratory Medicine. Comparison of pre-analytical conditions for quantification of serotonin in platelet-poor plasma
Even when handling is carefully controlled, a blood serotonin measurement still reflects the peripheral pool. There is research interest in whether peripheral serotonin levels can serve as a window into brain function, and some studies have found differences in platelet serotonin binding between people with depression and healthy controls.7JAMA Psychiatry. Depressed Patients Have Decreased Binding of Tritiated Imipramine to Platelet Serotonin ‘Transporter’ But findings across studies have been mixed, with some investigators replicating the result and others not.8PubMed. Further studies on platelet serotonin transporter binding in depression As of now, no blood-based serotonin measurement is accepted as a reliable diagnostic marker for any psychiatric condition.
How Diet and Medications Skew Results
If you are scheduled for a 5-HIAA urine collection, your doctor should give you a list of foods to avoid beforehand. Bananas, plantains, walnuts, pineapples, avocados, and certain other foods contain serotonin or its precursor tryptophan in amounts large enough to push 5-HIAA readings up and create a false positive. Tryptophan-containing supplements have the same effect and need to be stopped before testing.9PubMed Central. Urinary sampling for 5HIAA and metanephrines determination: revisiting the recommendations A case report documented a patient whose elevated 5-HIAA was traced entirely to dietary intake, not to a tumor, which illustrates why test preparation instructions matter.4AACE Clinical Case Reports. Falsely Elevated 24-Hour Urine 5-Hydroxyindoleacetic Acid Due to Dietary Intake: A Case Report and Review of the Literature
Medications present an even bigger complication for blood serotonin measurement. Selective serotonin reuptake inhibitors, the most widely prescribed class of antidepressants, profoundly alter peripheral serotonin levels. SSRIs block the transporter that platelets use to absorb serotonin, so people taking these drugs end up with very low concentrations of free serotonin in their plasma.10PubMed. Use of selective serotonin reuptake inhibitors is associated with very low plasma-free serotonin concentrations in humans A systematic review confirmed that every study examining SSRI treatment separately found a drop in blood serotonin, regardless of which blood component was analyzed.11Progress in Neuro-Psychopharmacology and Biological Psychiatry. Peripheral serotonin levels as a predictor of antidepressant treatment response: A systematic review Interestingly, the size of that drop may matter: one study found that people who responded well to SSRIs had a larger decrease in blood serotonin than those who did not respond.12PubMed Central. Plasma Serotonin Levels are Associated with Antidepressant Response to SSRIs This is an active area of research, but it is not yet something used in routine clinical decisions.
Serotonin Syndrome Is a Bedside Diagnosis
One scenario where serotonin testing seems like it should be straightforward is serotonin syndrome, a potentially dangerous condition caused by too much serotonergic activity. You might expect that a blood test confirming high serotonin would clinch the diagnosis, but in practice the condition is identified through a physical exam and a careful medication review, not through lab work.13PubMed Central. Controversies in Serotonin Syndrome Diagnosis and Management: A Review The Hunter Serotonin Toxicity Criteria, a widely used diagnostic tool, rely on a handful of physical signs: certain types of involuntary muscle contractions, agitation, sweating, tremor, and overactive reflexes. In severe cases, muscle rigidity and fever above 38°C are also present.14PubMed. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity
The reason lab testing is not part of the diagnostic criteria is partly practical and partly physiological. Serotonin syndrome develops quickly and needs to be treated quickly. Waiting for lab results would delay care. And because the problem involves serotonin activity at brain receptors, a blood measurement of peripheral serotonin would not reliably reflect what is happening at the synapses causing the symptoms. Clinicians rely on pattern recognition instead.
Research Tools That Measure Brain Serotonin
If standard clinical tests cannot measure brain serotonin, how do researchers study it? Several techniques exist, though none are practical for routine diagnostic use.
The most widely used approach for human brain studies is PET imaging with specialized radioactive tracers that bind to serotonin receptors or transporters. PET scans can quantify how many serotonin receptors are available in specific brain regions and can measure how much of a receptor is occupied by a drug.15PubMed Central. PET tracers for serotonin receptors and their applications Researchers have used PET data from groups of people to estimate what “normal” receptor density looks like across the brain.16PubMed Central. Inter-individual variability of neurotransmitter receptor and transporter density in the human brain PET is invaluable for drug development and for understanding psychiatric conditions at a population level, but the scans are expensive, require injection of a radiotracer, and are available only at specialized centers. They also measure receptor availability rather than the moment-to-moment concentration of serotonin itself.
In animal research, microdialysis allows scientists to directly sample the fluid around neurons in real time. A tiny probe is inserted into a specific brain region, and the serotonin that diffuses across its membrane is collected and measured. This technique can capture real-time serotonin release under different conditions, such as during stress.17PubMed. In vivo measurement of hypothalamic serotonin release by intracerebral microdialysis: significant enhancement by immobilization stress in rats Faster versions of microdialysis have been developed to track changes on a timescale of seconds rather than minutes.18PubMed Central. Physiologically relevant changes in serotonin resolved by fast microdialysis Microdialysis is not used in human diagnostic medicine because it requires surgically implanting a probe in the brain, but it remains a cornerstone of serotonin research in laboratory settings.
Cerebrospinal fluid analysis sits somewhere between these extremes. A spinal tap can measure 5-HIAA levels in the fluid surrounding the brain and spinal cord, which gives a closer reflection of central serotonin metabolism than blood or urine. Researchers have used CSF 5-HIAA to study the effects of SSRIs on brain serotonin turnover, finding that chronic SSRI use decreases CSF 5-HIAA, likely because the drugs raise serotonin at the synapse, which triggers feedback mechanisms that slow production.19PubMed. Acute changes in cerebrospinal fluid 5-HIAA following oral paroxetine challenge in healthy humans Spinal taps are too invasive for routine mood assessments, but CSF analysis does have a genuine clinical application in diagnosing rare pediatric neurotransmitter disorders, where enzyme deficiencies disrupt serotonin and dopamine production. These conditions do not show up on standard blood tests and require CSF analysis for diagnosis.20PubMed Central. The pediatric neurotransmitter disorders
Tryptophan Depletion as a Functional Probe
Researchers have also developed indirect ways to gauge how the serotonin system is functioning without measuring serotonin itself. One of the most studied is acute tryptophan depletion, a method that temporarily lowers the brain’s raw material for making serotonin. Participants drink an amino acid mixture that is missing tryptophan, the dietary precursor to serotonin. The body’s protein-building machinery rapidly consumes the tryptophan already circulating in the blood, starving the brain of its supply. In animal models, this reliably reduces brain serotonin and its metabolite 5-HIAA within hours.21PLoS ONE. Effects of Acute Tryptophan Depletion on Brain Serotonin Function and Concentrations of Dopamine and Norepinephrine in C57BL/6J and BALB/cJ Mice
In human studies, tryptophan depletion does not necessarily change how well people perform cognitive tasks, but it does alter which brain regions are recruited during those tasks, as shown on functional MRI scans.22PubMed Central. Acute tryptophan depletion promotes an anterior-to-posterior fMRI activation shift during task switching in older adults The technique is purely a research tool, used to understand what serotonin does in the brain rather than to diagnose any clinical condition. But it has taught scientists a great deal about serotonin’s role in cognition, emotion regulation, and impulse control, which shapes how psychiatric treatments are developed.
Direct-to-Consumer Neurotransmitter Panels
You may have seen companies offering urine or saliva panels that claim to measure your neurotransmitter levels, including serotonin, dopamine, and others, often marketed toward people dealing with depression, anxiety, or fatigue. These tests do detect neurotransmitter metabolites in urine, and the chemistry behind the measurement is real. The problem is what those numbers mean.
Urinary neurotransmitter levels have not been accepted as diagnostic for depression or any other psychiatric condition. While some studies have found biochemical differences between groups, the evidence base does not support using these tests to diagnose individual patients or to guide treatment decisions with confidence. The suggestion from the research community has been that urinary testing might eventually help predict treatment response in clinical settings, but that application remains preliminary and is not part of standard psychiatric care.23Neuroscience and Biobehavioral Reviews. Neurotransmitters excreted in the urine as biomarkers of nervous system activity: Validity and clinical applicability If a wellness company tells you that your low urinary serotonin means you are serotonin-deficient and should buy their supplement, be skeptical. The gap between what the test measures and what they are claiming it means is wide.
Genetic Testing and the Serotonin System
Another approach that sometimes gets discussed is genetic testing for serotonin-related genes, particularly variations in the serotonin transporter gene. One well-studied variant, known as 5-HTTLPR, comes in a “short” and “long” version, and earlier research suggested that the long version was associated with more serotonin transporter production. That finding came from lab-grown cell lines, though. When researchers looked at actual human brain tissue to see whether the genetic variant affected serotonin transporter binding in the prefrontal cortex, they found no significant difference between people carrying the long versus short versions.24Archives of General Psychiatry. A Serotonin Transporter Gene Promoter Polymorphism (5-HTTLPR) and Prefrontal Cortical Binding in Major Depression and Suicide Controlling for depression history or sex did not change that result.
This is a recurring theme in serotonin genetics: a variant looks promising in a lab dish or a small study, and then the effect evaporates or shrinks when tested in a more clinically meaningful context. Pharmacogenomic panels that test for serotonin-related gene variants are available and sometimes marketed as tools to personalize antidepressant selection, but their clinical utility remains debated. They can flag certain drug metabolism differences, which has some practical value, but they do not measure your actual serotonin activity or reliably predict whether a specific SSRI will work for you.
When Serotonin Testing Genuinely Helps
Despite all these caveats, there are clear situations where serotonin-related testing provides actionable medical information. The 5-HIAA urine test remains a frontline tool in the workup for carcinoid tumors and is standard practice in neuroendocrine oncology.25Oriental Journal Of Chemistry. A Review on 5-Hydroxyindoleacetic Acid (5-HIAA) in Urine: Diagnostic and Therapeutic Implications for Carcinoid Tumours CSF neurotransmitter analysis is essential for diagnosing rare inborn errors of neurotransmitter metabolism in children, where early identification can lead to treatment that dramatically changes outcomes. Blood serotonin levels, while not diagnostic for mood disorders, are occasionally ordered to rule out serotonin-producing tumors or to monitor treatment of known carcinoid disease.
For the much larger group of people who wonder about their serotonin in the context of depression or anxiety, the honest answer is that no currently available test will give you a meaningful number to act on. Psychiatric diagnosis and treatment decisions are based on symptoms, history, and clinical judgment, not on a serotonin lab value. That may feel unsatisfying, but it reflects the genuine state of the science. The brain’s serotonin system is not like blood sugar, where a single number reliably tracks a treatable condition. It involves multiple receptor types spread across dozens of brain regions, fluctuating on timescales of milliseconds, and interacting with other neurotransmitter systems in ways that a single measurement cannot capture. The tools to probe this complexity exist in research settings, but translating them into a useful clinical test for individual patients remains one of psychiatry’s open problems.